TriAltus Bioscience Launches Phi29 DNA Polymerase
January 14, 2025
We're pleased to introduce Phi29 DNA polymerase to our enzyme portfolio. By leveraging our exclusive CLÄ«M purification platform, we're able to deli...
TriAltus Bioscience Protein Purification Technology Supports Providence Cancer Institute COVID-19 Vaccine Development
April 16, 2020
Novel CL7/Im7 system enables rapid, high-purity, high-yield production of Coronavirus S-Spike proteins for research
BIRMINGHAM, Ala.–(BUSINESS WI...
TriAltus Bioscience to Present Abstract on Single-Step Cas9 Protein Purification with CL7/Im7 Affinity Tag System at PepTalk 2020
January 14, 2020
Breakthrough technique enables rapid, high-purity production of Cas9 proteins supporting accurate and efficient CRISPR genome editing
BIRMING...
TriAltus Bioscience Launches Im7 Affinity Chromatography Resin with Increased Binding Capacity
November 18, 2019
Modification doubles binding capacity for CL7/Im7 single-step protein purification system
BIRMINGHAM, Ala. – TriAltus Bioscience, LLC today annou...
Chinese Scientists Use TriAltus Bioscience’s CL-7 Purification System to Purify CRISPR-associated Proteins
August 29, 2018
BIRMINGHAM, Ala. (August 29, 2018)—TriAltus Bioscience, LLC today announced that scientists at Hubei University in China successfully co-expressed...
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
